18 Recruiting Inflammatory Bowel Disease (IBD) Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by Study Phase
Related Conditions
Top Recruiting Inflammatory Bowel Disease (IBD) Studies
Evaluating the Shift From Intravenous to Subcutaneous Vedolizumab for Inflammatory Bowel Disease
📍 Vanderbilt University Medical Center — Nashville, Tennessee
View Study & Checklist ➔Use of Fidaxomicin Compared to Vancomycin for Decolonization of C. Difficile in Patients With Inflammatory Bowel Disease
📍 Brigham and Women's Hospital — Boston, Massachusetts
View Study & Checklist ➔VR Therapies for IBD
📍 Cedars-Sinai Medical Center — Los Angeles, California
View Study & Checklist ➔Pilot Trial of Xylitol for C. Difficile De-Colonization in Patients With Inflammatory Bowel Disease
📍 Brigham and Women's Hospital — Boston, Massachusetts
View Study & Checklist ➔Visualization of the Colon Through Use of the Magnetic Flexible Endoscope (MFE) in Participants With Inflammatory Bowel Disease (IBD)
📍 Vanderbilt University Medical Center — Nashville, Tennessee
View Study & Checklist ➔Evaluation of the SMART IBD App in Pediatric IBD
📍 Cincinnati Children's Hospital Medical Center — Cincinnati, Ohio
View Study & Checklist ➔Clinical Investigation of MYIBDDiet App Developed for Inflammatory Bowel Disease (IBD) Patients to Self-manage Their Diet
📍 Zeidler Ledcor Centre, University of Alberta — Edmonton, Alberta
View Study & Checklist ➔IBD Pregnancy Registry
📍 PPD — Wilmington, North Carolina
View Study & Checklist ➔Study of Efficacy and Adherence to Subcutaneous vs. Intravenous Vedolizumab in Patients With Inflammatory Bowel Disease Using a Novel Remote MONITORing Intervention
📍 Tulane University — New Orleans, Louisiana
View Study & Checklist ➔Study of DISC-0974-201 in Participants With IBD and Anemia
📍 One of a Kind Clinical Research Center, LLC — Scottsdale, Arizona
View Study & Checklist ➔Family Members At INcreased-risk for Developing Inflammatory Bowel Disease
📍 Massachusetts General Hospital — Boston, Massachusetts
View Study & Checklist ➔Switching to the IL-23 Inhibitor Guselkumab for People With Active IBD Who Previously Used Ustekinumab (SHIFT-IBD)
📍 University of Calgary — Calgary, Alberta
View Study & Checklist ➔A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
📍 Mirador Therapeutics Selected Site — Birmingham, Alabama
View Study & Checklist ➔